ML P17 2 mg (Doxazosin Mesylate 2 mg)
Pill with imprint ML P17 2 mg is Yellow, Elliptical / Oval and has been identified as Doxazosin Mesylate 2 mg. It is supplied by Dava Pharmaceuticals Inc..
Doxazosin is used in the treatment of benign prostatic hyperplasia; raynaud's syndrome; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ML P17 2 mg
Doxazosin Mesylate
- Imprint
- ML P17 2 mg
- Strength
- 2 mg
- Color
- Yellow
- Size
- 10.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dava Pharmaceuticals Inc.
- National Drug Code (NDC)
- 67253-0381
- Inactive Ingredients
-
microcrystalline cellulose,
sodium starch glycolate type B potato,
magnesium stearate,
sodium lauryl sulfate,
D&C Yellow No. 10,
FD&C Yellow No. 6,
aluminum oxide,
lactose
Note: Inactive ingredients may vary.
More about doxazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 42 Reviews
- Drug class: antiadrenergic agents, peripherally acting
Consumer resources
- Patient Information
- Doxazosin (Advanced Reading)
- Doxazosin Extended-Release Tablets
- Doxazosin Tablets
- Other brands
- Cardura, Cardura XL
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.